Sanofi Pasteur MSD Limited

Mallards Reach, Bridge Avenue, Maidenhead, Berkshire, SL6 1QP
Telephone: +44 (0)1628 785 291
Fax: +44 (0)1628 671 722
Medical Information Direct Line: +44 (0)1628 587 693
Medical Information e-mail: medinfo@spmsd.com
Medical Information Fax: +44 (0)1628 635 072

Patient Information Leaflet last updated on the eMC: 26/11/2010
PIL AVAXIM

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 26/11/2010 and displayed until Current
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 13/05/2009 and displayed until 26/11/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 21/03/2007 and displayed until 13/05/2009
Reasons for adding or updating:
  • Change to manufacturer contact details
  • Change to date of revision
Updated on 13/09/2006 and displayed until 21/03/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 08/05/2006 and displayed until 13/09/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 20/04/2006 and displayed until 08/05/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   hepatitis a vaccine (inactivated, adsorbed)